Evidence map›Paper›PMID 25782665›Full record

ArticleScientific reports2015

Differentiation of human induced pluripotent stem cells to mature functional Purkinje neurons.

Shuyan Wang, Bin Wang, Na Pan, Linlin Fu, Chaodong Wang, Gongru Song, Jing An, Zhongfeng Liu, Wanwan Zhu, Yunqian Guan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Modeling Human Cerebellar Development In Vitro in 2D Structure.Journal of visualized experiments : JoVE · 2022
    Article
  10. Article
  11. Human organoids in basic research and clinical applications.Signal transduction and targeted therapy · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Stem Cell Therapy in Treating Epilepsy.Frontiers in neuroscience · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Shuyan Wang1] Sanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China [2] Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, China [3] Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, China.
Bin WangSanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Na PanDepartment of Neurobiology, Beijing Key Laboratory of Major Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, 100069, China.
Linlin FuSanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Chaodong WangDepartment of Neurobiology, Xuanwu Hosptial, Capital Medical University, Beijing, 100053, China.
Gongru SongSanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Jing AnSanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Zhongfeng LiuSanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Wanwan ZhuSanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Yunqian GuanSanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Zhi-Qing David XuDepartment of Neurobiology, Beijing Key Laboratory of Major Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, 100069, China.
Piu Chan1] Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, China [2] Department of Neurobiology, Xuanwu Hosptial, Capital Medical University, Beijing, 100053, China.
Zhiguo Chen1] Sanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China [2] Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, China [3] Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, China.
Y Alex Zhang1] Sanofi-Xuanwu Joint Lab for Regenerative Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China [2] China R&D Center, Sanofi, Beijing 100022, China.
Capital Medical University · CNChinese Institute for Brain Research · CNSanofi (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It remains a challenge to differentiate human induced pluripotent stem cells (iPSCs) or embryonic stem (ES) cells to Purkinje cells. In this study, we derived iPSCs from human fibroblasts and directed the specification of iPSCs first to Purkinje progenitors, by adding Fgf2 and insulin to the embryoid bodies (EBs) in a time-sensitive manner, which activates the endogenous production of Wnt1 and Fgf8 from EBs that further patterned the cells towards a midbrain-hindbrain-boundary tissue identity. Neph3-positive human Purkinje progenitors were sorted out by using flow cytometry and cultured either alone or with granule cell precursors, in a 2-dimensional or 3-dimensional environment. However, Purkinje progenitors failed to mature further under above conditions. By co-culturing human Purkinje progenitors with rat cerebellar slices, we observed mature Purkinje-like cells with right morphology and marker expression patterns, which yet showed no appropriate membrane properties. Co-culture with human fetal cerebellar slices drove the progenitors to not only morphologically correct but also electrophysiologically functional Purkinje neurons. Neph3-posotive human cells could also survive transplantation into the cerebellum of newborn immunodeficient mice and differentiate to L7- and Calbindin-positive neurons. Obtaining mature human Purkinje cells in vitro has significant implications in studying the mechanisms of spinocerebellar ataxias and other cerebellar diseases.

Indexed as

AnimalsCell Culture TechniquesCell DifferentiationCells, CulturedCerebellumCoculture TechniquesFibroblast Growth Factor 2HumansImmunoglobulinsImmunohistochemistryInduced Pluripotent Stem CellsInsulinMembrane ProteinsMiceMice, SCIDMicroscopy, FluorescencecyclopamineFibroblast Growth Factor 2ImmunoglobulinsInsulinKIRREL2 protein, humanMembrane ProteinsVeratrum Alkaloids

Identifiers

PMID25782665
PMCPMC4363833
OpenAlexW2030470560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.